Pharma with 2,330 puts trading, or 1.1x expected. Most active are 2/14 weekly 36 puts and 2/28 weekly 36 puts, ...

Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

GlaxoSmithKline Pharma Ltd announced its Q3 results today posting a solid jump in its net profit. Consolidated PAT for the ...

GSK plc (LON:GSK – Get Free Report) insider Emma Walmsley sold 120,653 shares of the firm’s stock in a transaction on Monday, ...

A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 32 tables and 44 figures, this 110-page report ?Asia Pacific Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1 ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 67 tables and 51 figures, this 131-page report ?Asia Pacific Small Molecule API Market 2022-2032 by Source (Synthetic, Semi ...

Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...

Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand.

GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...

A few notable health care deals along with M&A in the AI-adjacent and reshoring themes occurred in January. Read more here.